Clario
Buying intent
101 tracked signals | Top 15 topics are below | HR and Security are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Clario's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
5d ago
5d ago
16d ago
5d ago
11d ago
16d ago
7d ago
17d ago
17d ago
16d ago
16d ago
11d ago
16d ago
16d ago
18d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Clario
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
11 people across every department at Clario, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileClario specializes in providing advanced endpoint technology services for clinical trial management, focusing on generating high-quality clinical evidence through innovative solutions for cardiac safety and efficacy monitoring across various trial phas...
New capability sought
Employee posts (LinkedIn)Drug Development; Healthcare Interoperability; Medical Imaging; Operational Excellence; Patient-Reported Outcomes (PROs); Product Management; Recruiting Software / Services
Top accounts researching Clario
names withheld on the public pageThese are companies whose own people brought up Clario unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
3,463 companies · 13,523 people are researching Clinical Trials
Clario's own team shows 20 signals on this topic. No one outside Clario has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Pharmaceutical5,568 cos · 20,395 people
- Hiring66,174 cos · 318,882 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)HR / Talent — 3 people; IT — 1 person; Security — 1 person
What's been said
public posts mentioning ClarioUp to 9 public excerpts naming Clario from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
Neuroscience clinical trials need high-precision and sensitive endpoint measurements. But many of us know how quickly things can get complicated with subjective assessments, rater variability, participant burden, and time-intensive data analysis. That's why I’m excited for this free Clario webinar on May 13 at 11:00 a.m. ET. We’ll hear how newer applications of artificial intelligence are being explored across the neuroscience trial journey, with a focus on using AI responsibly in clinical development. Speakers will include: • Todd Rudo, MD, EVP and Chief Medical Officer • Mark Opler, Ph.D., Chief Research Officer, eCOA Neuroscience • Alex Boudreau, Director, AI • Joël Schaerer, Ph.D., Senior Director, Imaging AI Don't miss it! Register here: https://lnkd.in/dAfYsRnG
Apr 2026